Geron Corporation

Overview

Geron Corporation is a biotechnology company based in Foster City, California. The organization specializes in developing and commercializing therapeutic products to treat blood cancers, particularly hematologic malignancies, with a focus on telomerase inhibition—a distinct strategy targeting a key enzyme active in many forms of cancer.

The company’s flagship product, RYTELO (imetelstat), is approved for adult patients with low- to intermediate-1 risk myelodysplastic syndromes who are transfusion-dependent. Geron is committed to advancing innovative therapies that improve and extend the lives of individuals battling blood cancers. Its core mission is to drive scientific excellence and patient-centric innovation in oncology therapeutics.

Basic Information

Contact Details

• Phone: +1 650-473-7700
• Website: geron.com
• LinkedIn: linkedin.com/company/geron

Key Focus Areas & Initiatives

• Oncology
• Telomerase inhibition
• Blood cancer research
• Therapeutic product development
• Cancer cell biology and targeting
• Imetelstat & telomerase inhibitor therapies
• Biopharmaceutical innovation
• Research in hematologic malignancies
• Targeted cancer therapies
• Clinical development and regulatory approval

Technologies Used

• AI
• BugHerd
• DNS Made Easy
• Google Font API
• Google Tag Manager
• Microsoft Office 365
• Mimecast
• Mobile Friendly
• Outlook
• Remote
• WordPress.org

Affiliated Organizations & Regional Branches